Antidote for Acetaminophen Poisoning

Inhibiting liver enzyme activity to prevent the generation of toxic metabolites of acetaminophen known to cause liver damage.

1. Received TFDA orphan drug designation.
2. SNP-820 is the effective antidote component of SNP-810, and has been approved by TFDA to conduct Phase II clinical trial in patients with acetaminophen poisoning.

1. The efficacy is better than the current standard of treatment (N-acetylcysteine).
2. The detoxification ingredients are the same as some of the ingredients of SNP-810, which can prove the efficacy of each other.

SNP-820 is medically important even though the market is not big. SINEW has developed SNP-820 as social welfare.